Page last updated: 2024-09-05

lanthanum carbonate and losartan potassium

lanthanum carbonate has been researched along with losartan potassium in 1 studies

Compound Research Comparison

Studies
(lanthanum carbonate)
Trials
(lanthanum carbonate)
Recent Studies (post-2010)
(lanthanum carbonate)
Studies
(losartan potassium)
Trials
(losartan potassium)
Recent Studies (post-2010) (losartan potassium)
3908721824,3902,4935,408

Protein Interaction Comparison

ProteinTaxonomylanthanum carbonate (IC50)losartan potassium (IC50)
Bile salt export pumpHomo sapiens (human)8.53
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.0082
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0049
Type-2 angiotensin II receptorRattus norvegicus (Norway rat)0.0082
5-hydroxytryptamine receptor 1AMus musculus (house mouse)0.0082
Type-1 angiotensin II receptorCavia porcellus (domestic guinea pig)0.018

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, M; Kitai, M; Maruyama, N; Maruyama, T; Nagura, C; Otsuki, T; Shibahara, N; Tomita, H; Yoshida, Y1

Trials

1 trial(s) available for lanthanum carbonate and losartan potassium

ArticleYear
Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients.
    American journal of nephrology, 2018, Volume: 47, Issue:6

    Topics: Erythropoietin; Female; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Lanthanum; Male; Middle Aged; Prospective Studies; Renal Dialysis; Treatment Outcome

2018